Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis

[1]  M. Emdin,et al.  When the heart is burning: amino-terminal pro-brain natriuretic peptide as an early marker of cardiac involvement in active autoimmune rheumatic disease. , 2011, International journal of cardiology.

[2]  G. Giannakoulas,et al.  Early Detection of Cardiac Involvement in Systemic Sclerosis Assessed by Tissue-Doppler Echocardiography: Relationship with Neurohormonal Activation and Endothelial Dysfunction , 2010, The Journal of Rheumatology.

[3]  G. Giannakoulas,et al.  Natriuretic peptides in systemic sclerosis-related pulmonary arterial hypertension. , 2010, Seminars in arthritis and rheumatism.

[4]  M. Garcés,et al.  Potential biomarkers for detecting pulmonary arterial hypertension in patients with systemic sclerosis , 2009, Rheumatology International.

[5]  M. Humbert,et al.  The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France. , 2009, Arthritis and rheumatism.

[6]  G. Giannakoulas,et al.  Asymmetrical dimethylarginine in systemic sclerosis-related pulmonary arterial hypertension. , 2008, Rheumatology.

[7]  S. Hazen,et al.  Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure. , 2008, European heart journal.

[8]  M. Tsapenko,et al.  Arterial pulmonary hypertension in noncardiac intensive care unit , 2008, Vascular health and risk management.

[9]  L. Mouthon,et al.  Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: A controlled study of 100 consecutive patients. , 2008, Arthritis and rheumatism.

[10]  C. Taege,et al.  Right-heart failure after right heart catheterization in a patient with scleroderma and suspected pulmonary hypertension , 2008, Rheumatology International.

[11]  G. Lippi,et al.  N-terminal pro-BNP in sclerodermic patients on bosentan therapy for PAH , 2008, Rheumatology International.

[12]  F. Triposkiadis,et al.  Left atrial remodelling contributes to the progression of asymptomatic left ventricular systolic dysfunction to chronic symptomatic heart failure , 2008, Heart Failure Reviews.

[13]  G. Giannakoulas,et al.  N-Terminal probrain natriuretic peptide as a biochemical marker in the evaluation of bosentan treatment in systemic-sclerosis-related pulmonary arterial hypertension , 2008, Clinical Rheumatology.

[14]  P. V. van Riel,et al.  Right ventricle Tei-index: a tool to increase the accuracy of non-invasive detection of pulmonary arterial hypertension in connective tissue diseases. , 2007, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[15]  G. Giannakoulas,et al.  Neurohormonal activation in patients with systemic sclerosis-related pulmonary arterial hypertension. , 2007, International Journal of Cardiology.

[16]  T. Medsger,et al.  Changes in causes of death in systemic sclerosis, 1972–2002 , 2007, Annals of the rheumatic diseases.

[17]  F. Triposkiadis,et al.  Left Αtrial Remodeling in Patients Younger than 70 Years with Diastolic and Systolic Heart Failure , 2007 .

[18]  Z. Jing,et al.  Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. , 2006, Journal of the American College of Cardiology.

[19]  M. Kurzyna,et al.  Non-invasive diagnostic and functional evaluation of cardiac involvement in patients with systemic sclerosis , 2006, Clinical Rheumatology.

[20]  M. Lempereur,et al.  Determinants of pulmonary artery hypertension at rest and during exercise in patients with heart failure. , 2006, European heart journal.

[21]  J. Krishnan,et al.  Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. , 2006, Arthritis and rheumatism.

[22]  C. Black,et al.  Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine. , 2006, Rheumatology.

[23]  C. Denton,et al.  Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension. , 2006, European heart journal.

[24]  M. Humbert,et al.  Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. , 2005, Arthritis and rheumatism.

[25]  P. Sampaio-Barros,et al.  Prevalence of pulmonary hypertension in systemic sclerosis. , 2005, Clinical and experimental rheumatology.

[26]  M. Baron,et al.  Prevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosis. , 2005, The Journal of rheumatology.

[27]  F. Manguso,et al.  Echocardiographic alterations in systemic sclerosis: a longitudinal study. , 2005, Seminars in arthritis and rheumatism.

[28]  R. D. du Bois,et al.  Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. , 2004, Rheumatology.

[29]  A. Holmes,et al.  Significance of plasma N-terminal pro-brain natriuretic peptide in patients with systemic sclerosis-related pulmonary arterial hypertension. , 2003, Respiratory medicine.

[30]  C. Denton,et al.  Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach , 2003, Annals of the rheumatic diseases.

[31]  A. Wiik,et al.  The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis. , 2003, Rheumatology.

[32]  James B Seward,et al.  Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. , 2002, The American journal of cardiology.

[33]  G. Valentini,et al.  Right ventricular diastolic abnormalities in systemic sclerosis. Relation to left ventricular involvement and pulmonary hypertension , 2000, Annals of the rheumatic diseases.

[34]  J B Seward,et al.  Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension. , 1998, The American journal of cardiology.

[35]  A J Tajik,et al.  Doppler echocardiographic index for assessment of global right ventricular function. , 1996, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[36]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[37]  J. Seward,et al.  Continuous-wave Doppler echocardiographic assessment of severity of calcific aortic stenosis: a simultaneous Doppler-catheter correlative study in 100 adult patients. , 1985, Circulation.

[38]  J. Ross,et al.  Two-dimensional echocardiographic determination of left atrial emptying volume: a noninvasive index in quantifying the degree of nonrheumatic mitral regurgitation. , 1983, Journal of the American College of Cardiology.

[39]  A. Masi.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.

[40]  James F. Fries,et al.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.

[41]  D. Abraham,et al.  Neuronal regulators and vascular dysfunction in Raynaud's phenomenon and systemic sclerosis. , 2009, Current vascular pharmacology.

[42]  G. Giannakoulas,et al.  N-terminal pro-brain natriuretic peptide in systemic sclerosis related pulmonary arterial hypertension under bosentan treatment , 2008, Rheumatology International.

[43]  D. Borderie,et al.  High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis. , 2008, Arthritis and rheumatism.

[44]  R A Nishimura,et al.  Assessment of right atrial pressure with 2-dimensional and Doppler echocardiography: a simultaneous catheterization and echocardiographic study. , 2000, Mayo Clinic proceedings.